These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acharya S; Mishra A; Paul D; Ansari AH; Azhar M; Kumar M; Rauthan R; Sharma N; Aich M; Sinha D; Sharma S; Jain S; Ray A; Jain S; Ramalingam S; Maiti S; Chakraborty D Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20959-20968. PubMed ID: 31570623 [TBL] [Abstract][Full Text] [Related]
4. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652 [TBL] [Abstract][Full Text] [Related]
8. A highly specific SpCas9 variant is identified by in vivo screening in yeast. Casini A; Olivieri M; Petris G; Montagna C; Reginato G; Maule G; Lorenzin F; Prandi D; Romanel A; Demichelis F; Inga A; Cereseto A Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739 [TBL] [Abstract][Full Text] [Related]
9. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA. Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021 [TBL] [Abstract][Full Text] [Related]
10. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory]. Wang GH; Wang CM; Wu XJ; Chu T; Huang DW; Li J Mol Biol (Mosk); 2024; 58(1):157-159. PubMed ID: 38943587 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9. Choi GCG; Zhou P; Yuen CTL; Chan BKC; Xu F; Bao S; Chu HY; Thean D; Tan K; Wong KH; Zheng Z; Wong ASL Nat Methods; 2019 Aug; 16(8):722-730. PubMed ID: 31308554 [TBL] [Abstract][Full Text] [Related]
13. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9. Maji B; Gangopadhyay SA; Lee M; Shi M; Wu P; Heler R; Mok B; Lim D; Siriwardena SU; Paul B; Dančík V; Vetere A; Mesleh MF; Marraffini LA; Liu DR; Clemons PA; Wagner BK; Choudhary A Cell; 2019 May; 177(4):1067-1079.e19. PubMed ID: 31051099 [TBL] [Abstract][Full Text] [Related]
14. Generation of genetically modified mice using SpCas9-NG engineered nuclease. Fujii W; Ito H; Kanke T; Ikeda A; Sugiura K; Naito K Sci Rep; 2019 Sep; 9(1):12878. PubMed ID: 31501500 [TBL] [Abstract][Full Text] [Related]
15. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells. Donohoue PD; Pacesa M; Lau E; Vidal B; Irby MJ; Nyer DB; Rotstein T; Banh L; Toh MS; Gibson J; Kohrs B; Baek K; Owen ALG; Slorach EM; van Overbeek M; Fuller CK; May AP; Jinek M; Cameron P Mol Cell; 2021 Sep; 81(17):3637-3649.e5. PubMed ID: 34478654 [TBL] [Abstract][Full Text] [Related]
16. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants. Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740 [TBL] [Abstract][Full Text] [Related]
18. Catalytically Enhanced Cas9 through Directed Protein Evolution. Hand TH; Roth MO; Smith CL; Shiel E; Klein KN; Gilbert DM; Li H CRISPR J; 2021 Apr; 4(2):223-232. PubMed ID: 33876948 [TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides. Cui YR; Wang SJ; Chen J; Li J; Chen W; Wang S; Meng B; Zhu W; Zhang Z; Yang B; Jiang B; Yang G; Ma P; Liu J Genome Biol; 2020 Feb; 21(1):51. PubMed ID: 32102684 [TBL] [Abstract][Full Text] [Related]
20. Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate Specificity. Hand TH; Das A; Roth MO; Smith CL; Jean-Baptiste UL; Li H ACS Synth Biol; 2018 Dec; 7(12):2908-2917. PubMed ID: 30458109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]